These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Completed, but no date Terminated||2012-001948-21||Open Phase II Study of Ketoconazole as Inhibitor of the Enzyme CYP17 in Locally Advanced or Disseminated Granulosa Cell Tumour of Ovary. GreKo Study.||bad-data|
|Completed, but no date Terminated||2013-003128-35||Open label phase II clinical trial of Orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors. The Greko II study.||bad-data|
|Ongoing||2015-004469-10||Open label phase II clinical trial of enzalutamide in metastatic or advanced non-resectable granulosa cell ovarian tumors. GreKo III study.||not-yet-due|
|Ongoing||2016-003946-99||A multicenter phase 2 study of nivolumab combined with ipilimumab in patients with pediatric solid tumors presenting in adulthood||not-yet-due|